BMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid Leukemia
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop
growing or die. Phase I trial to study the effectiveness of BMS-214662 in treating patients
who have acute leukemia, myelodysplastic syndrome, or chronic myeloid leukemia in blast phase